160 related articles for article (PubMed ID: 9705080)
1. Aromatase expression of human osteoblast-like cells.
Shozu M; Simpson ER
Mol Cell Endocrinol; 1998 Apr; 139(1-2):117-29. PubMed ID: 9705080
[TBL] [Abstract][Full Text] [Related]
2. Multiple splicing events involved in regulation of human aromatase expression by a novel promoter, I.6.
Shozu M; Zhao Y; Bulun SE; Simpson ER
Endocrinology; 1998 Apr; 139(4):1610-7. PubMed ID: 9528941
[TBL] [Abstract][Full Text] [Related]
3. Estrogen biosynthesis in THP1 cells is regulated by promoter switching of the aromatase (CYP19) gene.
Shozu M; Zhao Y; Simpson ER
Endocrinology; 1997 Dec; 138(12):5125-35. PubMed ID: 9389492
[TBL] [Abstract][Full Text] [Related]
4. Estrogen production and action.
Nelson LR; Bulun SE
J Am Acad Dermatol; 2001 Sep; 45(3 Suppl):S116-24. PubMed ID: 11511861
[TBL] [Abstract][Full Text] [Related]
5. Functional analysis of the I.3, I.6, pII and I.4 promoters of CYP19 (aromatase) gene in human osteoblasts and their role in vitamin D and dexamethasone stimulation.
Enjuanes A; Garcia-Giralt N; Supervía A; Nogués X; Ruiz-Gaspà S; Bustamante M; Mellibovsky L; Grinberg D; Balcells S; Díez-Pérez A
Eur J Endocrinol; 2005 Dec; 153(6):981-8. PubMed ID: 16322405
[TBL] [Abstract][Full Text] [Related]
6. Aromatase in bone cell: association with osteoporosis in postmenopausal women.
Nawata H; Tanaka S; Tanaka S; Takayanagi R; Sakai Y; Yanase T; Ikuyama S; Haji M
J Steroid Biochem Mol Biol; 1995 Jun; 53(1-6):165-74. PubMed ID: 7626449
[TBL] [Abstract][Full Text] [Related]
7. Aromatase expression in a human osteoblastic cell line increases in response to prostaglandin E(2) in a dexamethasone-dependent fashion.
Watanabe M; Noda M; Nakajin S
Steroids; 2007 Sep; 72(9-10):686-92. PubMed ID: 17614108
[TBL] [Abstract][Full Text] [Related]
8. 1,25-Dihydroxyvitamin D3 enhances the enzymatic activity and expression of the messenger ribonucleic acid for aromatase cytochrome P450 synergistically with dexamethasone depending on the vitamin D receptor level in cultured human osteoblasts.
Tanaka S; Haji M; Takayanagi R; Tanaka S; Sugioka Y; Nawata H
Endocrinology; 1996 May; 137(5):1860-9. PubMed ID: 8612525
[TBL] [Abstract][Full Text] [Related]
9. Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19).
Shozu M; Sumitani H; Segawa T; Yang HJ; Murakami K; Kasai T; Inoue M
J Clin Endocrinol Metab; 2002 Jun; 87(6):2540-8. PubMed ID: 12050211
[TBL] [Abstract][Full Text] [Related]
10. Dehydroepiandrosterone (DHEA) as a possible source for estrogen formation in bone cells: correlation between bone mineral density and serum DHEA-sulfate concentration in postmenopausal women, and the presence of aromatase to be enhanced by 1,25-dihydroxyvitamin D3 in human osteoblasts.
Takayanagi R; Goto K; Suzuki S; Tanaka S; Shimoda S; Nawata H
Mech Ageing Dev; 2002 Apr; 123(8):1107-14. PubMed ID: 12044960
[TBL] [Abstract][Full Text] [Related]
11. TGF-beta1 stimulates expression of the aromatase (CYP19) gene in human osteoblast-like cells and THP-1 cells.
Shozu M; Zhao Y; Simpson ER
Mol Cell Endocrinol; 2000 Feb; 160(1-2):123-33. PubMed ID: 10715546
[TBL] [Abstract][Full Text] [Related]
12. Forskolin and dexamethasone synergistically induce aromatase (CYP19) expression in the human osteoblastic cell line SV-HFO.
Watanabe M; Ohno S; Nakajin S
Eur J Endocrinol; 2005 Apr; 152(4):619-24. PubMed ID: 15817919
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 stimulates aromatase expression in endometriosis-derived stromal cells.
Noble LS; Takayama K; Zeitoun KM; Putman JM; Johns DA; Hinshelwood MM; Agarwal VR; Zhao Y; Carr BR; Bulun SE
J Clin Endocrinol Metab; 1997 Feb; 82(2):600-6. PubMed ID: 9024261
[TBL] [Abstract][Full Text] [Related]
14. Tumor necrosis factor-alpha stimulates aromatase gene expression in human adipose stromal cells through use of an activating protein-1 binding site upstream of promoter 1.4.
Zhao Y; Nichols JE; Valdez R; Mendelson CR; Simpson ER
Mol Endocrinol; 1996 Nov; 10(11):1350-7. PubMed ID: 8923461
[TBL] [Abstract][Full Text] [Related]
15. Dexamethasone, BMP-2, and 1,25-dihydroxyvitamin D enhance a more differentiated osteoblast phenotype: validation of an in vitro model for human bone marrow-derived primary osteoblasts.
Jørgensen NR; Henriksen Z; Sørensen OH; Civitelli R
Steroids; 2004 Apr; 69(4):219-26. PubMed ID: 15183687
[TBL] [Abstract][Full Text] [Related]
16. Tamoxifen attenuates glucocorticoid actions on bone formation in vitro.
Sukhu B; Rotenberg B; Binkert C; Kohno H; Zohar R; McCulloch CA; Tenenbaum HC
Endocrinology; 1997 Aug; 138(8):3269-75. PubMed ID: 9231777
[TBL] [Abstract][Full Text] [Related]
17. Regulation of CYP19 gene expression in primary human osteoblasts: effects of vitamin D and other treatments.
Enjuanes A; Garcia-Giralt N; Supervia A; Nogués X; Mellibovsky L; Carbonell J; Grinberg D; Balcells S; Díez-Pérez A
Eur J Endocrinol; 2003 May; 148(5):519-26. PubMed ID: 12720534
[TBL] [Abstract][Full Text] [Related]
18. Glucocorticoid regulation of alkaline phosphatase, osteocalcin, and proto-oncogenes in normal human osteoblast-like cells.
Subramaniam M; Colvard D; Keeting PE; Rasmussen K; Riggs BL; Spelsberg TC
J Cell Biochem; 1992 Dec; 50(4):411-24. PubMed ID: 1469072
[TBL] [Abstract][Full Text] [Related]
19. Aromatase in aging women.
Bulun SE; Zeitoun K; Sasano H; Simpson ER
Semin Reprod Endocrinol; 1999; 17(4):349-58. PubMed ID: 10851574
[TBL] [Abstract][Full Text] [Related]
20. [Effect of cyproterone acetate on aromatase activity in cultured human genital skin fibroblasts: intracellular control of aromatase activity].
Fujimoto M
Nihon Naibunpi Gakkai Zasshi; 1989 Jun; 65(6):585-602. PubMed ID: 2551746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
